{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:25:14Z","timestamp":1762521914523},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Alder Hey Children's Kidney Fund","award":["UOG10065"],"award-info":[{"award-number":["UOG10065"]}]},{"name":"UK Experimental Arthritis Treatment Centre for Children"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clim.2016.06.010","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T17:13:22Z","timestamp":1467393202000},"page":"21-31","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Urinary biomarkers in childhood lupus nephritis"],"prefix":"10.1016","volume":"185","author":[{"given":"Eve M.D.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clim.2016.06.010_bb0005","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.34410","article-title":"Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort","volume":"64","author":"Watson","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2016.06.010_bb0010","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/rheumatology\/34.9.866","article-title":"Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome","volume":"34","author":"Tucker","year":"1995","journal-title":"Br. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.23204","article-title":"Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus","volume":"58","author":"Brunner","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.clim.2016.06.010_bb0025","first-page":"2635","article-title":"Longterm followup of childhood lupus nephritis","volume":"29","author":"Hagelberg","year":"2002","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2013-000004","article-title":"Value of repeat biopsy in lupus nephritis flares","volume":"1","author":"Greloni","year":"2014","journal-title":"Lupus Sci. Med."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3899\/jrheum.130005","article-title":"Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment","volume":"41","author":"Touma","year":"2014","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/rheumatology\/keu343","article-title":"Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus","volume":"54","author":"Ishizaki","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.clim.2016.06.010_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203313518625","article-title":"The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients","volume":"23","author":"Alvarado","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2016.06.010_bb0055","doi-asserted-by":"crossref","first-page":"106904","DOI":"10.1155\/2015\/106904","article-title":"The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy","volume":"2015","author":"Moroni","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"11","key":"10.1016\/j.clim.2016.06.010_bb0060","first-page":"1891","article-title":"Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies?","volume":"23","author":"Esdaile","year":"1996","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.clim.2016.06.010_bb0065","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome","volume":"37","author":"Steiman","year":"2010","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/ard.62.5.435","article-title":"Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment","volume":"62","author":"Fiehn","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.clim.2016.06.010_bb0075","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the euro-lupus nephritis trial","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2016.06.010_bb0080","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2362.2012.02674.x","article-title":"Implementation of proteomic biomarkers: making it work","volume":"42","author":"Mischak","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0961203307087875","article-title":"Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)","volume":"17","author":"Tucker","year":"2008","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.clim.2016.06.010_bb0090","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0961203314563817","article-title":"Similarities and differences between pediatric and adult patients with systemic lupus erythematosus","volume":"24","author":"Tarr","year":"2015","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/ard.2008.094813","article-title":"Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus","volume":"68","author":"Hoffman","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0100","first-page":"788","article-title":"Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population","volume":"33","author":"Martinez-Barrio","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2016.06.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/0961203316644333","article-title":"Differences in disease phenotype and severity in SLE across age groups","author":"Ambrose","year":"2016","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/rheumatology\/ket330","article-title":"Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan","volume":"53","author":"Chen","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00467-006-0286-0","article-title":"Clinical outcomes of childhood lupus nephritis: a single center's experience","volume":"22","author":"Lee","year":"2007","journal-title":"Pediatr. Nephrol."},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0120","first-page":"303","article-title":"Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus","volume":"66","author":"Marini","year":"1999","journal-title":"Rev. Rhum. Engl. Ed."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1681\/ASN.2006070767","article-title":"Urine biomarkers predict the cause of glomerular disease","volume":"18","author":"Varghese","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.clim.2016.06.010_bb0130","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/j.jprot.2012.03.034","article-title":"Urinary proteomics revealed prostaglandin H(2)D-isomerase, not Zn-alpha2-glycoprotein, as a biomarker for active lupus nephritis","volume":"75","author":"Somparn","year":"2012","journal-title":"J. Proteome"},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1203\/PDR.0b013e31819e4305","article-title":"Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis","volume":"65","author":"Suzuki","year":"2009","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00467-012-2184-y","article-title":"Urine biomarkers in juvenile-onset SLE nephritis","volume":"28","author":"Watson","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.clim.2016.06.010_bb0145","doi-asserted-by":"crossref","first-page":"180605","DOI":"10.1155\/2013\/180605","article-title":"Current status and advances in quantitative proteomic mass spectrometry","volume":"2013","author":"Wasinger","year":"2013","journal-title":"Int. J. Proteomics"},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0150","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1021\/pr2003038","article-title":"A comprehensive map of the human urinary proteome","volume":"10","author":"Marimuthu","year":"2011","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1523-1755.2003.00840.x","article-title":"Pathophysiology of proteinuria","volume":"63","author":"D'Amico","year":"2003","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-010-8207-1","article-title":"Histopathology of lupus nephritis","volume":"40","author":"Giannakakis","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0165","first-page":"185","article-title":"HLA-Dr+T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus","volume":"59","author":"Caligaris-Cappio","year":"1985","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.1986.105","article-title":"Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates","volume":"29","author":"Boucher","year":"1986","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2016.06.010_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13075-015-0600-y","article-title":"The cellular signature of urinary immune cells in lupus nephritis: new insights into potential biomarkers","volume":"17","author":"Kopetschke","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0180","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/annrheumdis-2012-202784","article-title":"Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response","volume":"73","author":"Enghard","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0185","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/ar4189","article-title":"Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis","volume":"15","author":"Dolff","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.clim.2016.06.010_bb0190","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/rheumatology\/ket108","article-title":"Urinary free light chain is a potential biomarker for ISN\/RPS class III\/IV lupus nephritis","volume":"52","author":"Hanaoka","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0200","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ki.1996.105","article-title":"Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis","volume":"49","author":"Wada","year":"1996","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.clim.2016.06.010_bb0205","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/ndt\/gfn270","article-title":"Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis","volume":"23","author":"Marks","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0210","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/0961203311431249","article-title":"Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus","volume":"21","author":"Watson","year":"2012","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0215","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3912","article-title":"Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis","volume":"14","author":"Singh","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0220","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s10875-011-9555-1","article-title":"Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis","volume":"31","author":"El-Shehaby","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1681\/ASN.2004080658","article-title":"Urine chemokines as biomarkers of human systemic lupus erythematosus activity","volume":"16","author":"Rovin","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.clim.2016.06.010_bb0230","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00467-010-1605-z","article-title":"Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis","volume":"25","author":"Marks","year":"2010","journal-title":"Pediatr. Nephrol."},{"issue":"10","key":"10.1016\/j.clim.2016.06.010_bb0235","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3899\/jrheum.081112","article-title":"Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis","volume":"36","author":"Kiani","year":"2009","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.clim.2016.06.010_bb0240","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3899\/jrheum.110201","article-title":"Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients","volume":"39","author":"Rosa","year":"2012","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0245","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4103\/1319-2442.157350","article-title":"Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children","volume":"26","author":"Ghobrial","year":"2015","journal-title":"Saudi J. Kidney Dis. Transpl."},{"issue":"23\u201324","key":"10.1016\/j.clim.2016.06.010_bb0250","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.cca.2011.07.023","article-title":"Urinary monocyte chemoattractant protein-1 in renal disease","volume":"412","author":"Kim","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0255","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00467-013-2668-4","article-title":"Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study","volume":"29","author":"Watson","year":"2013","journal-title":"Pediatr. Nephrol."},{"issue":"11","key":"10.1016\/j.clim.2016.06.010_bb0260","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/0961203312452622","article-title":"Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare","volume":"21","author":"Singh","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0265","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0961203313484977","article-title":"Urinary CXCL-10\/IP-10 and MCP-1 as markers to assess activity of lupus nephritis","volume":"22","author":"Abujam","year":"2013","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.clim.2016.06.010_bb0270","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00011-007-6147-x","article-title":"Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare","volume":"56","author":"Tian","year":"2007","journal-title":"Inflamm. Res."},{"issue":"8","key":"10.1016\/j.clim.2016.06.010_bb0275","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1681\/ASN.2006121348","article-title":"Spiegelmer inhibition of CCL2\/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice","volume":"18","author":"Kulkarni","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0280","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.108.142711","article-title":"Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice","volume":"328","author":"Kulkarni","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.clim.2016.06.010_bb0285","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/dom.12309","article-title":"CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study","volume":"16","author":"Di Prospero","year":"2014","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0290","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.pain.2013.02.003","article-title":"A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia","volume":"154","author":"Kalliomaki","year":"2013","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.clim.2016.06.010_bb0295","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1074\/jbc.M413192200","article-title":"Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro","volume":"280","author":"Gwira","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2016.06.010_bb0300","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1196\/annals.1398.032","article-title":"Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis","volume":"1109","author":"Schwartz","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.clim.2016.06.010_bb0305","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00467-006-0146-y","article-title":"Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury","volume":"21","author":"Trachtman","year":"2006","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0310","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000078452","article-title":"Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity","volume":"24","author":"Mishra","year":"2004","journal-title":"Am. J. Nephrol."},{"issue":"10","key":"10.1016\/j.clim.2016.06.010_bb0315","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","volume":"14","author":"Mishra","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0320","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.autrev.2007.11.013","article-title":"The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)\/lipocalin-2 as a biomarker for lupus nephritis","volume":"7","author":"Rubinstein","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0325","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","article-title":"Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis","volume":"54","author":"Haase","year":"2009","journal-title":"Am. J. Kidney Dis."},{"issue":"9466","key":"10.1016\/j.clim.2016.06.010_bb0330","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.2010.351","article-title":"Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation","volume":"79","author":"Hollmen","year":"2011","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.clim.2016.06.010_bb0340","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/art.22008","article-title":"Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus","volume":"54","author":"Brunner","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2016.06.010_bb0345","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.34426","article-title":"Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis","volume":"64","author":"Brunner","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0350","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/0961203313479419","article-title":"Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children","volume":"22","author":"Hammad","year":"2013","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0355","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/art.22594","article-title":"Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis","volume":"56","author":"Pitashny","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.06.010_bb0360","doi-asserted-by":"crossref","first-page":"759313","DOI":"10.1155\/2012\/759313","article-title":"Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus","volume":"2012","author":"Yang","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0365","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00467-007-0685-x","article-title":"Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis","volume":"23","author":"Suzuki","year":"2008","journal-title":"Pediatr. Nephrol."},{"issue":"9","key":"10.1016\/j.clim.2016.06.010_bb0370","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/art.24751","article-title":"Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity","volume":"60","author":"Hinze","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0375","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/rheumatology\/kep468","article-title":"Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis","volume":"49","author":"Rubinstein","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0380","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3899\/jrheum.111470","article-title":"Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis","volume":"39","author":"Kiani","year":"2012","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.clim.2016.06.010_bb0385","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.4049\/jimmunol.179.10.7166","article-title":"Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis","volume":"179","author":"Wu","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0390","first-page":"403","article-title":"Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage","volume":"20","author":"Molad","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0395","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10157-010-0322-z","article-title":"Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings","volume":"14","author":"Abd-Elkareem","year":"2010","journal-title":"Clin. Exp. Nephrol."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0400","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1756-185X.2012.01720.x","article-title":"Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis","volume":"15","author":"Howe","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0405","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar2816","article-title":"Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study","volume":"11","author":"Schwartz","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0410","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1797.2011.01449.x","article-title":"Gene expression of TWEAK\/Fn14 and IP-10\/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis","volume":"16","author":"Lu","year":"2011","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0415","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.05.003","article-title":"Role of TWEAK in lupus nephritis: a bench-to-bedside review","volume":"39","author":"Michaelson","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2016.06.010_bb0420","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fimmu.2013.00473","article-title":"TWEAK\/Fn14 Axis-targeted therapeutics: moving basic science discoveries to the clinic","volume":"4","author":"Cheng","year":"2013","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0425","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2014030233","article-title":"Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis","volume":"26","author":"Xia","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0430","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2006.12.003","article-title":"Urinary TWEAK and the activity of lupus nephritis","volume":"27","author":"Schwartz","year":"2006","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2016.06.010_bb0435","doi-asserted-by":"crossref","first-page":"359647","DOI":"10.1155\/2012\/359647","article-title":"Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases","volume":"2012","author":"Xuejing","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0440","first-page":"16","article-title":"Urinary levels of IL-6 in patients with active lupus nephritis","volume":"40","author":"Iwano","year":"1993","journal-title":"Clin. Nephrol."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0445","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000045663","article-title":"Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis","volume":"85","author":"Tsai","year":"2000","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0450","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2005.10.006","article-title":"Urinary biomarkers in lupus nephritis","volume":"5","author":"Li","year":"2006","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0455","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.24136","article-title":"CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients","volume":"60","author":"Enghard","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.clim.2016.06.010_bb0460","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.V10122518","article-title":"Role for interactions between IP-10\/Mig and CXCR3 in proliferative glomerulonephritis","volume":"10","author":"Romagnani","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.clim.2016.06.010_bb0465","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3899\/jrheum.120177","article-title":"Relationship of intrarenal gene expression and the histological class of lupus nephritis \u2013 a study on repeat renal biopsy","volume":"39","author":"Lu","year":"2012","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0470","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.ki.5000132","article-title":"Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis","volume":"69","author":"Avihingsanon","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2016.06.010_bb0475","article-title":"Development of a novel renal activity index of lupus nephritis in children & young adults","author":"Brunner","year":"2015","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0480","doi-asserted-by":"crossref","first-page":"610","DOI":"10.5301\/jn.5000233","article-title":"Urinary proteome in a snapshot: normal urine and glomerulonephritis","volume":"26","author":"Santucci","year":"2013","journal-title":"J. Nephrol."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0485","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1523-1755.2004.00352.x","article-title":"Urine protein profiling with surface-enhanced laser-desorption\/ionization time-of-flight mass spectrometry","volume":"65","author":"Schaub","year":"2004","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.clim.2016.06.010_bb0490","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2009.01.019","article-title":"Proteomic toolbox for autoimmunity research","volume":"8","author":"Wu","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.clim.2016.06.010_bb0495","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gpb.2013.05.003","article-title":"Biomarker profiling for lupus nephritis","volume":"11","author":"Li","year":"2013","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"12","key":"10.1016\/j.clim.2016.06.010_bb0500","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/rheumatology\/kel351","article-title":"Urinary proteomic profiles distinguish between active and inactive lupus nephritis","volume":"45","author":"Mosley","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0505","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1111\/j.1523-1755.2005.00730.x","article-title":"Prediction of urinary protein markers in lupus nephritis","volume":"68","author":"Oates","year":"2005","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0510","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.2008.316","article-title":"Biomarkers of lupus nephritis determined by serial urine proteomics","volume":"74","author":"Zhang","year":"2008","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.clim.2016.06.010_bb0515","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00467-007-0608-x","article-title":"Identification of a urinary proteomic signature for lupus nephritis in children","volume":"22","author":"Suzuki","year":"2007","journal-title":"Pediatr. Nephrol."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0520","first-page":"367","article-title":"Assessment of lupus nephritis activity using urinary retinol-binding protein","volume":"9","author":"Sesso","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0525","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00467-004-1707-6","article-title":"Renal tubular dysfunction in children with systemic lupus erythematosus","volume":"20","author":"Marks","year":"2005","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0530","first-page":"694","article-title":"Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study","volume":"33","author":"Gupta","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2016.06.010_bb0535","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/jcla.21685","article-title":"A study of hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus","volume":"28","author":"Mohammed","year":"2014","journal-title":"J. Clin. Lab. Anal."},{"issue":"14","key":"10.1016\/j.clim.2016.06.010_bb0540","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1177\/0961203314547797","article-title":"Urine beta2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus","volume":"23","author":"Choe","year":"2014","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0545","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1074\/mcp.M112.021667","article-title":"Urinary angiostatin\u2013a novel putative marker of renal pathology chronicity in lupus nephritis","volume":"12","author":"Wu","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.clim.2016.06.010_bb0550","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.4049\/jimmunol.163.5.2883","article-title":"Inducible expression and regulation of the alpha 1-acid glycoprotein gene by alveolar macrophages: prostaglandin E2 and cyclic AMP act as new positive stimuli","volume":"163","author":"Fournier","year":"1999","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0555","first-page":"530","article-title":"Human endothelial cells produce orosomucoid, an important component of the capillary barrier","volume":"276","author":"Sorensson","year":"1999","journal-title":"Am. J. Phys."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0560","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1348-0421.1984.tb02950.x","article-title":"Cultured human monocytes, granulocytes and a monoblastoid cell line (THP-1) synthesize and secrete immunosuppressive acidic protein (a type of alpha 1-acid glycoprotein)","volume":"28","author":"Shibata","year":"1984","journal-title":"Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0565","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00916390","article-title":"Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis","volume":"17","author":"Nakamura","year":"1993","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0570","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.148.2.507","article-title":"Leukocyte surface origin of human alpha1-acid glycoprotein (orosomucoid)","volume":"148","author":"Gahmberg","year":"1978","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138920307779941497","article-title":"The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases","volume":"8","author":"Ceciliani","year":"2007","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1\u20132","key":"10.1016\/j.clim.2016.06.010_bb0580","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0167-4838(00)00161-8","article-title":"Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase","volume":"1482","author":"Urade","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2016.06.010_bb0585","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu. Rev. Nutr."},{"issue":"11","key":"10.1016\/j.clim.2016.06.010_bb0590","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/rheumatology\/kep221","article-title":"Iron homoeostasis in rheumatic disease","volume":"48","author":"Baker","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clim.2016.06.010_bb0595","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0961203302lu131oa","article-title":"Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"11","author":"Navarro","year":"2002","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.clim.2016.06.010_bb0600","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/HJH.0000000000000019","article-title":"Hypertension increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin in normoalbuminuric patients with type 2 diabetes mellitus","volume":"32","author":"Ohara","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.clim.2016.06.010_bb0605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-800094-6.00003-0","article-title":"Urine retinol-binding protein 4: a functional biomarker of the proximal renal tubule","volume":"63","author":"Norden","year":"2014","journal-title":"Adv. Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.clim.2016.06.010_bb0610","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0009-8981(01)00586-1","article-title":"Hemopexin: a review of biological aspects and the role in laboratory medicine","volume":"312","author":"Delanghe","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clim.2016.06.010_bb0615","first-page":"w13743","article-title":"Metabolomics\u2013a novel window into inflammatory disease","volume":"143","author":"Fitzpatrick","year":"2013","journal-title":"Swiss Med. Wkly."},{"issue":"6","key":"10.1016\/j.clim.2016.06.010_bb0620","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/ar3530","article-title":"Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis","volume":"13","author":"Romick-Rosendale","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"5\u20136","key":"10.1016\/j.clim.2016.06.010_bb0625","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jchromb.2009.01.007","article-title":"Normalization strategies for metabonomic analysis of urine samples","volume":"877","author":"Warrack","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616301188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616301188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T23:06:19Z","timestamp":1692399979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616301188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":125,"alternative-id":["S1521661616301188"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.06.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary biomarkers in childhood lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}